ISIN | AT0000A0XMM2 |
---|---|
Valor Number | 19994591 |
Bloomberg Global ID | |
Fund Name | DSC Equity Fund – Healthcare A |
Fund Provider |
Dreyfus Söhne & Cie AG, Banquiers
Aeschenvorstadt 16 | Postfach 4051 Basel Schweiz Phone: +41 61 286 66 66 Web: https://www.dreyfusbank.ch |
Fund Provider | Dreyfus Söhne & Cie AG, Banquiers |
Representative in Switzerland |
Dreyfus Söhne & Cie AG, Banquiers Basel |
Distributor(s) |
Dreyfus Söhne & Cie AG, Banquiers Basel |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Austria |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 190.08 CHF | 18.08.2025 |
---|---|---|
Previous Price * | 186.27 CHF | 14.08.2025 |
52 Week High * | 239.85 CHF | 03.09.2024 |
52 Week Low * | 180.97 CHF | 08.08.2025 |
NAV * | 190.08 CHF | 18.08.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 30,798,117 | |
Unit/Share Assets *** | 1,198,067 | |
Trading Information SIX |
YTD Performance | -12.66% |
30.12.2024 - 18.08.2025
30.12.2024 18.08.2025 |
---|---|---|
1 month | +2.54% |
18.07.2025 - 18.08.2025
18.07.2025 18.08.2025 |
3 months | -2.70% |
19.05.2025 - 18.08.2025
19.05.2025 18.08.2025 |
6 months | -15.44% |
18.02.2025 - 18.08.2025
18.02.2025 18.08.2025 |
1 year | -19.93% |
19.08.2024 - 18.08.2025
19.08.2024 18.08.2025 |
2 years | -9.70% |
18.08.2023 - 18.08.2025
18.08.2023 18.08.2025 |
3 years | -15.44% |
18.08.2022 - 18.08.2025
18.08.2022 18.08.2025 |
5 years | -11.21% |
18.08.2020 - 18.08.2025
18.08.2020 18.08.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
iShares MSCI Wld HlthCrSect AdvcdETF$Inc | 7.64% | |
---|---|---|
Eli Lilly and Co | 7.05% | |
Johnson & Johnson | 6.73% | |
Abbott Laboratories | 5.15% | |
AbbVie Inc | 4.13% | |
UnitedHealth Group Inc | 3.93% | |
Merck & Co Inc | 3.68% | |
AstraZeneca PLC | 3.35% | |
Intuitive Surgical Inc | 3.19% | |
Sanofi SA | 3.13% | |
Last data update | 30.06.2025 |
TER | 1.53% |
---|---|
TER date | 30.04.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.49% |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |